HH
Insider
Hans van Houte
Chief Financial OfficerHans van Houte (Chief Financial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Nurix Therapeutics, Inc. (NRIX). The largest single filing was $223K of NRIX (13,473 sh × $16.58, as filed), executed May 5.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$223K
shares × price, as filed
Last traded
May 5
Filed May 5
Median ADV $54.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $223K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
NRIXRecent filings
NRIXSALE
Nurix Therapeutics, Inc.
View filing →
$223K13,473 sh × $16.58
Exec May 5
Filed May 5 · 5:30 PM ET